$1.84
11.53% today
Nasdaq, Dec 30, 09:46 pm CET
ISIN
IL0011050551
Symbol
EVGN
Sector
Industry

Evogene Ltd Target price 2024 - Analyst rating & recommendation

Evogene Ltd Classifications & Recommendation:

Buy
100%

Evogene Ltd Price Target

Target Price $8.13
Price $1.65
Potential
Number of Estimates 2
2 Analysts have issued a price target Evogene Ltd 2025 . The average Evogene Ltd target price is $8.13. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 2 analysts: 2 Analysts recommend Evogene Ltd to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Evogene Ltd stock has an average upside potential 2025 of . Most analysts recommend the Evogene Ltd stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 5.64 10.53
235.71% 86.61%
EBITDA Margin -421.63% -165.97%
73.90% 60.64%

2 Analysts have issued a sales forecast Evogene Ltd 2024 . The average Evogene Ltd sales estimate is

$10.5m
Unlock
. This is
40.71% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$10.7m 42.38%
Unlock
, the lowest is
$10.4m 39.04%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $5.6m 235.71%
2024
$10.5m 86.61%
Unlock
2025
$14.6m 38.72%
Unlock
2026
$26.0m 78.25%
Unlock
2027
$44.9m 72.49%
Unlock
2028
$63.1m 40.48%
Unlock

2 Analysts have issued an Evogene Ltd EBITDA forecast 2024. The average Evogene Ltd EBITDA estimate is

$-17.5m
Unlock
. This is
21.21% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-16.7m 24.67%
Unlock
, the lowest is
$-18.2m 17.74%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $-23.8m 12.38%
2024
$-17.5m 26.54%
Unlock
2025
$-17.5m 0.25%
Unlock
2026
$-12.3m 29.59%
Unlock
2027
$-3.8m 69.50%
Unlock
2028
$4.1m 210.24%
Unlock

EBITDA Margin

2023 -421.63% 73.90%
2024
-165.97% 60.64%
Unlock
2025
-119.95% 27.73%
Unlock
2026
-47.38% 60.50%
Unlock
2027
-8.38% 82.31%
Unlock
2028
6.57% 178.40%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
EV/Sales 0.59

Based on analysts' sales estimates for 2024, the Evogene Ltd stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.82 82.99%
2024
0.59 28.51%
Unlock
2025
0.42 27.91%
Unlock
2026
0.24 43.89%
Unlock
2027
0.14 42.05%
Unlock
2028
0.10 28.82%
Unlock

P/S ratio

Current 1.18 81.36%
2024
0.84 28.93%
Unlock
2025
0.61 27.91%
Unlock
2026
0.34 43.90%
Unlock
2027
0.20 42.05%
Unlock
2028
0.14 28.82%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today